Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization

被引：14

作者：

Doctor, Priyanka P. ^{[1
]}

Bhat, Pooja ^{[1
]}

Sayed, Reema ^{[1
]}

Foster, C. Stephen ^{[1
]}

机构：

[1] Massachusetts Eye Res & Surg Inst, Cambridge, MA 02142 USA

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2009年 / 17卷 / 02期

关键词：

inflammatory choroidal neovascularization; intravitreal bevacizumab; uveitic CNV; PHOTODYNAMIC THERAPY; SUBFOVEAL; AVASTIN; SECONDARY; INJECTION;

D O I：

10.1080/09273940802650406

中图分类号：

R77 [眼科学];

学科分类号：

100212 [眼科学];

摘要：

Purpose: To report 5 cases of inflammatory choroidal neovascularization (CNV) that were treated with intravitreal bevacizumab. Methods: Six eyes of 5 patients with uveitic CNV were treated with 2.5 mg/0.1 mL of intravitreal bevacizumab. Main outcome measures were the changes in BCVA and reduction in the size of the CNV. Results: The mean follow-up time was 15.3 months. The mean intravitreal injections administered were 2.7. All patients showed a reduction in the size of the CNV with improvement in BCVA in 60% of cases at the last follow-up. Conclusion: Intravitreal bevacizumab may provide an additional strategy in the management of inflammatory CNV.

引用

页码：118 / 126

页数：9

共 21 条

[1]

Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis [J].

Adán, A ;

Mateo, C ;

Wolley-Dod, C .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (03) :386-387

[2]

Intravitreal bevacizumab (Avastin) injection as primary treatment of inflammatory choroidal neovascularization [J].

Adan, Alfredo ;

Mateo, Carlos ;

Navarro, Rafael ;

Bitrian, Elena ;

Casaroli-Marano, Ricardo P. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (09) :1180-1186

[3]

[Anonymous], 1991, Arch Ophthalmol, V109, P1109

[4]

Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model [J].

Bakri, Sophie J. ;

Cameron, J. Douglas ;

McCannel, Colin A. ;

Pulido, Jose S. ;

Marler, Ronald J. .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (01) :162-164

[5]

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study [J].

Bashshur, Ziad F. ;

Haddad, Zeina A. ;

Schakal, Alexandre ;

Jaafar, Rola F. ;

Saab, Marc ;

Noureddin, Baha' N. .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (02) :249-256

[6]

Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis [J].

Berger, AS ;

Conway, M ;

DelPriore, LV ;

Walker, RS ;

Pollack, JS ;

Kaplan, HJ .

ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (08) :991-996

[7]

Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin [J].

Chan, Wai-Man ;

Lai, Timothy Y. Y. ;

Liu, David T. L. ;

Lam, Dennis S. C. .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (06) :977-983

[8]

Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy [J].

Coco, Rosa M. ;

de Souza, Clairton Feitosa ;

Sanabria, M. Rosa .

OCULAR IMMUNOLOGY AND INFLAMMATION, 2007, 15 (01) :27-29

[9]

Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization [J].

Grossniklaus, HE ;

Green, WR .

ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (06) :745-749

[10]

Hernández-Rojas ML, 2007, RETINA-J RET VIT DIS, V27, P707

← 1 2 3 →